Insider Trading Alert - PRXL, SCOR And HLF Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 6, 2014, 103 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $555.82 to $40,491,464.00.

Highlighted Stocks Traded by Insiders:

Parexel International (PRXL) - FREE Research Report

Lindop Christopher J, who is Director at Parexel International, sold 12,000 shares at $55.00 on Nov. 6, 2014. Following this transaction, the Director owned 20,255 shares meaning that the stake was reduced by 37.2% with the 12,000-share transaction.

The shares most recently traded at $53.69, down $1.31, or 2.44% since the insider transaction. Historical insider transactions for Parexel International go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 6,800
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 6,800
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 15,800

The average volume for Parexel International has been 711,500 shares per day over the past 30 days. Parexel International has a market cap of $2.9 billion and is part of the health care sector and health services industry. Shares are up 18.42% year-to-date as of the close of trading on Thursday.

PAREXEL International Corporation is a biopharmaceutical outsourcing services company. The company has a P/E ratio of 21.4. Currently, there are 6 analysts who rate Parexel International a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PRXL - FREE

TheStreet Quant Ratings rates Parexel International as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Parexel International Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

comScore (SCOR) - FREE Research Report

Lin Christiana L, who is General Counsel at comScore, sold 1,000 shares at $42.30 on Nov. 6, 2014. Following this transaction, the General Counsel owned 59,517 shares meaning that the stake was reduced by 1.65% with the 1,000-share transaction.

Meierhoefer Cameron, who is Chief Operating Officer at comScore, sold 1,200 shares at $42.30 on Nov. 6, 2014. Following this transaction, the Chief Operating Officer owned 41,392 shares meaning that the stake was reduced by 2.82% with the 1,200-share transaction.

The shares most recently traded at $42.75, up $0.45, or 1.05% since the insider transaction. Historical insider transactions for comScore go as follows:

  • 4-Week # shares sold: 2,200
  • 12-Week # shares sold: 25,405
  • 24-Week # shares sold: 241,905

The average volume for comScore has been 206,900 shares per day over the past 30 days. comScore has a market cap of $1.5 billion and is part of the services sector and diversified services industry. Shares are up 50.23% year-to-date as of the close of trading on Thursday.

comScore, Inc. provides a range of digital media analytics solutions in the United States, Europe, Canada, and others. Currently, there are 3 analysts who rate comScore a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on SCOR - FREE

TheStreet Quant Ratings rates comScore as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share. Get the full comScore Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Herbalife (HLF) - FREE Research Report

Pezzullo David, who is EVP WW Operations at Herbalife, bought 1,220 shares at $40.98 on Nov. 6, 2014. Following this transaction, the EVP WW Operations owned 58,735 shares meaning that the stake was boosted by 2.12% with the 1,220-share transaction.

The shares most recently traded at $38.25, down $2.73, or 7.14% since the insider transaction. Historical insider transactions for Herbalife go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 13,240
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 13,240
  • 24-Week # shares bought: 44,900
  • 24-Week # shares sold: 16,215

The average volume for Herbalife has been 2.2 million shares per day over the past 30 days. Herbalife has a market cap of $3.7 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are down 49.19% year-to-date as of the close of trading on Thursday.

Herbalife Ltd., a nutrition company, sells weight management, healthy meals and snacks, sports and fitness, energy and targeted nutritional products, and personal care products worldwide. The company has a P/E ratio of 11.8. Currently, there are 2 analysts who rate Herbalife a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HLF - FREE

TheStreet Quant Ratings rates Herbalife as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, weak operating cash flow and a generally disappointing performance in the stock itself. Get the full Herbalife Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Global Stocks Slide as Yield Pressure, Commodity Surge Prompts Equity Exit

Global Stocks Slide as Yield Pressure, Commodity Surge Prompts Equity Exit

Asian Markets Decline in Morning Trading

Asian Markets Decline in Morning Trading

Verizon Proves Resilient in Sell-Off; Decoding the Facebook Short -- ICYMI

Verizon Proves Resilient in Sell-Off; Decoding the Facebook Short -- ICYMI

Three Big Factors That Rocked the Stock Market Tuesday

Three Big Factors That Rocked the Stock Market Tuesday

Dow Tumbles Over 400 Points; S&P 500 and Nasdaq Also Finish Lower

Dow Tumbles Over 400 Points; S&P 500 and Nasdaq Also Finish Lower